Global SHR0302 Market Growth 2026-2032
The global SHR0302 market size is predicted to grow from US$ 264 million in 2025 to US$ 1238 million in 2032; it is expected to grow at a CAGR of 17.9% from 2026 to 2032.
SHR0302 (generic name: Ivarmacitinib) is a highly selective oral JAK1 inhibitor independently developed by Hengrui Medicine. By selectively inhibiting Janus kinase 1 (JAK1), it regulates the signaling pathways of key inflammatory cytokines such as IL?4, IL?13, IL?23, and IFN??, thereby suppressing abnormal immune activation and inflammatory responses. It is mainly indicated for the treatment of a variety of autoimmune and inflammatory skin diseases as well as rheumatic immune disorders. As a new generation of highly selective JAK inhibitors, it exhibits higher subtype selectivity for JAK1, which helps reduce the risk of adverse reactions associated with non-selective inhibition while ensuring therapeutic efficacy. Its approved or investigational indications include atopic dermatitis, rheumatoid arthritis, psoriasis, alopecia areata, vitiligo, among others. As an important immune-targeted drug independently developed and commercialized in China, it demonstrates significant clinical application value and market potential.In 2025, global SHR0302 (Ivarmacitinib) production reached approximately 1.2?1.5 million bottles.
SHR0302 (Ivarmacitinib), as the first highly selective oral JAK1 inhibitor independently developed in China, is positioned at the core of the rapidly growing market for autoimmune diseases. Thanks to its high selectivity for JAK1, it achieves a favorable balance between efficacy and safety, effectively mitigating the risk of adverse reactions associated with non-selective JAK inhibitors. The drug has been approved for multiple indications including ankylosing spondylitis, rheumatoid arthritis, atopic dermatitis and alopecia areata, covering a large patient population.
On the market side, the global market for JAK inhibitors continues to expand, with the domestic market growing notably and long dominated by imported original research drugs. Relying on its advantages as a domestic innovative drug, cost-effective pricing strategy and prospects for medical insurance access, SHR0302 is expected to rapidly achieve import substitution. Meanwhile, the expansion of its indications and the research and development of topical formulations will further unlock its market potential.
In terms of competitive landscape, there are few similar products in China. Hengrui Medicine occupies a leading position in the domestic JAK1 inhibitor sector by virtue of its complete commercialization system and clinical resources. In the future, with the continuous approval of new indications, volume growth under medical insurance coverage and advancement of internationalization, SHR0302 is expected to become a benchmark product in the field of autoimmune diseases in China with sustainable long-term growth potential.
LP Information, Inc. (LPI) ' newest research report, the ?SHR0302 Industry Forecast? looks at past sales and reviews total world SHR0302 sales in 2025, providing a comprehensive analysis by region and market sector of projected SHR0302 sales for 2026 through 2032. With SHR0302 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world SHR0302 industry.
This Insight Report provides a comprehensive analysis of the global SHR0302 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on SHR0302 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global SHR0302 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for SHR0302 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global SHR0302.
This report presents a comprehensive overview, market shares, and growth opportunities of SHR0302 market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global SHR0302 market?
What factors are driving SHR0302 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do SHR0302 market opportunities vary by end market size?
How does SHR0302 break out by Type, by Application?
SHR0302 (generic name: Ivarmacitinib) is a highly selective oral JAK1 inhibitor independently developed by Hengrui Medicine. By selectively inhibiting Janus kinase 1 (JAK1), it regulates the signaling pathways of key inflammatory cytokines such as IL?4, IL?13, IL?23, and IFN??, thereby suppressing abnormal immune activation and inflammatory responses. It is mainly indicated for the treatment of a variety of autoimmune and inflammatory skin diseases as well as rheumatic immune disorders. As a new generation of highly selective JAK inhibitors, it exhibits higher subtype selectivity for JAK1, which helps reduce the risk of adverse reactions associated with non-selective inhibition while ensuring therapeutic efficacy. Its approved or investigational indications include atopic dermatitis, rheumatoid arthritis, psoriasis, alopecia areata, vitiligo, among others. As an important immune-targeted drug independently developed and commercialized in China, it demonstrates significant clinical application value and market potential.In 2025, global SHR0302 (Ivarmacitinib) production reached approximately 1.2?1.5 million bottles.
SHR0302 (Ivarmacitinib), as the first highly selective oral JAK1 inhibitor independently developed in China, is positioned at the core of the rapidly growing market for autoimmune diseases. Thanks to its high selectivity for JAK1, it achieves a favorable balance between efficacy and safety, effectively mitigating the risk of adverse reactions associated with non-selective JAK inhibitors. The drug has been approved for multiple indications including ankylosing spondylitis, rheumatoid arthritis, atopic dermatitis and alopecia areata, covering a large patient population.
On the market side, the global market for JAK inhibitors continues to expand, with the domestic market growing notably and long dominated by imported original research drugs. Relying on its advantages as a domestic innovative drug, cost-effective pricing strategy and prospects for medical insurance access, SHR0302 is expected to rapidly achieve import substitution. Meanwhile, the expansion of its indications and the research and development of topical formulations will further unlock its market potential.
In terms of competitive landscape, there are few similar products in China. Hengrui Medicine occupies a leading position in the domestic JAK1 inhibitor sector by virtue of its complete commercialization system and clinical resources. In the future, with the continuous approval of new indications, volume growth under medical insurance coverage and advancement of internationalization, SHR0302 is expected to become a benchmark product in the field of autoimmune diseases in China with sustainable long-term growth potential.
LP Information, Inc. (LPI) ' newest research report, the ?SHR0302 Industry Forecast? looks at past sales and reviews total world SHR0302 sales in 2025, providing a comprehensive analysis by region and market sector of projected SHR0302 sales for 2026 through 2032. With SHR0302 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world SHR0302 industry.
This Insight Report provides a comprehensive analysis of the global SHR0302 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on SHR0302 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global SHR0302 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for SHR0302 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global SHR0302.
This report presents a comprehensive overview, market shares, and growth opportunities of SHR0302 market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 4mg / tablet
- 8mg / tablet
- Oral Tablet
- Topical Ointment
- Gel Dosage Form
- Oral Administration
- Topical Administration
- Hospital
- Retail
- Online
- Inflammatory Skin Diseases Such As Atopic Dermatitis, Psoriasis, Vitiligo And Alopecia Areata
- Rheumatic Immune Diseases Such As Rheumatoid Arthritis And Ankylosing Spondylitis
- Other Autoimmune And Inflammatory Diseases Mediated By The JAK Pathway
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Jiangsu Hengrui Pharmaceuticals
- Arcutis Biotherapeutics
What is the 10-year outlook for the global SHR0302 market?
What factors are driving SHR0302 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do SHR0302 market opportunities vary by end market size?
How does SHR0302 break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global SHR0302 Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for SHR0302 by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for SHR0302 by Country/Region, 2021, 2025 & 2032
2.2 SHR0302 Segment by Type
2.2.1 4mg / tablet
2.2.2 8mg / tablet
2.2.3 SHR0302 Sales by Type
2.2.3.1 Global SHR0302 Sales Market Share by Type (2021-2026)
2.2.3.2 Global SHR0302 Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global SHR0302 Sale Price by Type (2021-2026)
2.3 SHR0302 Segment by Dosage Form
2.3.1 Oral Tablet
2.3.2 Topical Ointment
2.3.3 Gel Dosage Form
2.3.4 SHR0302 Sales by Dosage Form
2.3.4.1 Global SHR0302 Sales Market Share by Dosage Form (2021-2026)
2.3.4.2 Global SHR0302 Revenue and Market Share by Dosage Form (2021-2026)
2.3.4.3 Global SHR0302 Sale Price by Dosage Form (2021-2026)
2.4 SHR0302 Segment by Route of Administration
2.4.1 Oral Administration
2.4.2 Topical Administration
2.4.3 SHR0302 Sales by Route of Administration
2.4.3.1 Global SHR0302 Sales Market Share by Route of Administration (2021-2026)
2.4.3.2 Global SHR0302 Revenue and Market Share by Route of Administration (2021-2026)
2.4.3.3 Global SHR0302 Sale Price by Route of Administration (2021-2026)
2.5 SHR0302 Segment by Sales Channels
2.5.1 Hospital
2.5.2 Retail
2.5.3 Online
2.5.4 SHR0302 Sales by Sales Channels
2.5.4.1 Global SHR0302 Sales Market Share by Sales Channels (2021-2026)
2.5.4.2 Global SHR0302 Revenue and Market Share by Sales Channels (2021-2026)
2.5.4.3 Global SHR0302 Sale Price by Sales Channels (2021-2026)
2.6 SHR0302 Segment by Application
2.6.1 Inflammatory Skin Diseases Such As Atopic Dermatitis, Psoriasis, Vitiligo And Alopecia Areata
2.6.2 Rheumatic Immune Diseases Such As Rheumatoid Arthritis And Ankylosing Spondylitis
2.6.3 Other Autoimmune And Inflammatory Diseases Mediated By The JAK Pathway
2.6.4 Others
2.6.5 SHR0302 Sales by Application
2.6.5.1 Global SHR0302 Sale Market Share by Application (2021-2026)
2.6.5.2 Global SHR0302 Revenue and Market Share by Application (2021-2026)
2.6.5.3 Global SHR0302 Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global SHR0302 Breakdown Data by Company
3.1.1 Global SHR0302 Annual Sales by Company (2021-2026)
3.1.2 Global SHR0302 Sales Market Share by Company (2021-2026)
3.2 Global SHR0302 Annual Revenue by Company (2021-2026)
3.2.1 Global SHR0302 Revenue by Company (2021-2026)
3.2.2 Global SHR0302 Revenue Market Share by Company (2021-2026)
3.3 Global SHR0302 Sale Price by Company
3.4 Key Manufacturers SHR0302 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers SHR0302 Product Location Distribution
3.4.2 Players SHR0302 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SHR0302 BY GEOGRAPHIC REGION
4.1 World Historic SHR0302 Market Size by Geographic Region (2021-2026)
4.1.1 Global SHR0302 Annual Sales by Geographic Region (2021-2026)
4.1.2 Global SHR0302 Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic SHR0302 Market Size by Country/Region (2021-2026)
4.2.1 Global SHR0302 Annual Sales by Country/Region (2021-2026)
4.2.2 Global SHR0302 Annual Revenue by Country/Region (2021-2026)
4.3 Americas SHR0302 Sales Growth
4.4 APAC SHR0302 Sales Growth
4.5 Europe SHR0302 Sales Growth
4.6 Middle East & Africa SHR0302 Sales Growth
5 AMERICAS
5.1 Americas SHR0302 Sales by Country
5.1.1 Americas SHR0302 Sales by Country (2021-2026)
5.1.2 Americas SHR0302 Revenue by Country (2021-2026)
5.2 Americas SHR0302 Sales by Type (2021-2026)
5.3 Americas SHR0302 Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC SHR0302 Sales by Region
6.1.1 APAC SHR0302 Sales by Region (2021-2026)
6.1.2 APAC SHR0302 Revenue by Region (2021-2026)
6.2 APAC SHR0302 Sales by Type (2021-2026)
6.3 APAC SHR0302 Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe SHR0302 by Country
7.1.1 Europe SHR0302 Sales by Country (2021-2026)
7.1.2 Europe SHR0302 Revenue by Country (2021-2026)
7.2 Europe SHR0302 Sales by Type (2021-2026)
7.3 Europe SHR0302 Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa SHR0302 by Country
8.1.1 Middle East & Africa SHR0302 Sales by Country (2021-2026)
8.1.2 Middle East & Africa SHR0302 Revenue by Country (2021-2026)
8.2 Middle East & Africa SHR0302 Sales by Type (2021-2026)
8.3 Middle East & Africa SHR0302 Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of SHR0302
10.3 Manufacturing Process Analysis of SHR0302
10.4 Industry Chain Structure of SHR0302
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 SHR0302 Distributors
11.3 SHR0302 Customer
12 WORLD FORECAST REVIEW FOR SHR0302 BY GEOGRAPHIC REGION
12.1 Global SHR0302 Market Size Forecast by Region
12.1.1 Global SHR0302 Forecast by Region (2027-2032)
12.1.2 Global SHR0302 Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global SHR0302 Forecast by Type (2027-2032)
12.7 Global SHR0302 Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Jiangsu Hengrui Pharmaceuticals
13.1.1 Jiangsu Hengrui Pharmaceuticals Company Information
13.1.2 Jiangsu Hengrui Pharmaceuticals SHR0302 Product Portfolios and Specifications
13.1.3 Jiangsu Hengrui Pharmaceuticals SHR0302 Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
13.1.5 Jiangsu Hengrui Pharmaceuticals Latest Developments
13.2 Arcutis Biotherapeutics
13.2.1 Arcutis Biotherapeutics Company Information
13.2.2 Arcutis Biotherapeutics SHR0302 Product Portfolios and Specifications
13.2.3 Arcutis Biotherapeutics SHR0302 Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Arcutis Biotherapeutics Main Business Overview
13.2.5 Arcutis Biotherapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global SHR0302 Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for SHR0302 by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for SHR0302 by Country/Region, 2021, 2025 & 2032
2.2 SHR0302 Segment by Type
2.2.1 4mg / tablet
2.2.2 8mg / tablet
2.2.3 SHR0302 Sales by Type
2.2.3.1 Global SHR0302 Sales Market Share by Type (2021-2026)
2.2.3.2 Global SHR0302 Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global SHR0302 Sale Price by Type (2021-2026)
2.3 SHR0302 Segment by Dosage Form
2.3.1 Oral Tablet
2.3.2 Topical Ointment
2.3.3 Gel Dosage Form
2.3.4 SHR0302 Sales by Dosage Form
2.3.4.1 Global SHR0302 Sales Market Share by Dosage Form (2021-2026)
2.3.4.2 Global SHR0302 Revenue and Market Share by Dosage Form (2021-2026)
2.3.4.3 Global SHR0302 Sale Price by Dosage Form (2021-2026)
2.4 SHR0302 Segment by Route of Administration
2.4.1 Oral Administration
2.4.2 Topical Administration
2.4.3 SHR0302 Sales by Route of Administration
2.4.3.1 Global SHR0302 Sales Market Share by Route of Administration (2021-2026)
2.4.3.2 Global SHR0302 Revenue and Market Share by Route of Administration (2021-2026)
2.4.3.3 Global SHR0302 Sale Price by Route of Administration (2021-2026)
2.5 SHR0302 Segment by Sales Channels
2.5.1 Hospital
2.5.2 Retail
2.5.3 Online
2.5.4 SHR0302 Sales by Sales Channels
2.5.4.1 Global SHR0302 Sales Market Share by Sales Channels (2021-2026)
2.5.4.2 Global SHR0302 Revenue and Market Share by Sales Channels (2021-2026)
2.5.4.3 Global SHR0302 Sale Price by Sales Channels (2021-2026)
2.6 SHR0302 Segment by Application
2.6.1 Inflammatory Skin Diseases Such As Atopic Dermatitis, Psoriasis, Vitiligo And Alopecia Areata
2.6.2 Rheumatic Immune Diseases Such As Rheumatoid Arthritis And Ankylosing Spondylitis
2.6.3 Other Autoimmune And Inflammatory Diseases Mediated By The JAK Pathway
2.6.4 Others
2.6.5 SHR0302 Sales by Application
2.6.5.1 Global SHR0302 Sale Market Share by Application (2021-2026)
2.6.5.2 Global SHR0302 Revenue and Market Share by Application (2021-2026)
2.6.5.3 Global SHR0302 Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global SHR0302 Breakdown Data by Company
3.1.1 Global SHR0302 Annual Sales by Company (2021-2026)
3.1.2 Global SHR0302 Sales Market Share by Company (2021-2026)
3.2 Global SHR0302 Annual Revenue by Company (2021-2026)
3.2.1 Global SHR0302 Revenue by Company (2021-2026)
3.2.2 Global SHR0302 Revenue Market Share by Company (2021-2026)
3.3 Global SHR0302 Sale Price by Company
3.4 Key Manufacturers SHR0302 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers SHR0302 Product Location Distribution
3.4.2 Players SHR0302 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SHR0302 BY GEOGRAPHIC REGION
4.1 World Historic SHR0302 Market Size by Geographic Region (2021-2026)
4.1.1 Global SHR0302 Annual Sales by Geographic Region (2021-2026)
4.1.2 Global SHR0302 Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic SHR0302 Market Size by Country/Region (2021-2026)
4.2.1 Global SHR0302 Annual Sales by Country/Region (2021-2026)
4.2.2 Global SHR0302 Annual Revenue by Country/Region (2021-2026)
4.3 Americas SHR0302 Sales Growth
4.4 APAC SHR0302 Sales Growth
4.5 Europe SHR0302 Sales Growth
4.6 Middle East & Africa SHR0302 Sales Growth
5 AMERICAS
5.1 Americas SHR0302 Sales by Country
5.1.1 Americas SHR0302 Sales by Country (2021-2026)
5.1.2 Americas SHR0302 Revenue by Country (2021-2026)
5.2 Americas SHR0302 Sales by Type (2021-2026)
5.3 Americas SHR0302 Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC SHR0302 Sales by Region
6.1.1 APAC SHR0302 Sales by Region (2021-2026)
6.1.2 APAC SHR0302 Revenue by Region (2021-2026)
6.2 APAC SHR0302 Sales by Type (2021-2026)
6.3 APAC SHR0302 Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe SHR0302 by Country
7.1.1 Europe SHR0302 Sales by Country (2021-2026)
7.1.2 Europe SHR0302 Revenue by Country (2021-2026)
7.2 Europe SHR0302 Sales by Type (2021-2026)
7.3 Europe SHR0302 Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa SHR0302 by Country
8.1.1 Middle East & Africa SHR0302 Sales by Country (2021-2026)
8.1.2 Middle East & Africa SHR0302 Revenue by Country (2021-2026)
8.2 Middle East & Africa SHR0302 Sales by Type (2021-2026)
8.3 Middle East & Africa SHR0302 Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of SHR0302
10.3 Manufacturing Process Analysis of SHR0302
10.4 Industry Chain Structure of SHR0302
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 SHR0302 Distributors
11.3 SHR0302 Customer
12 WORLD FORECAST REVIEW FOR SHR0302 BY GEOGRAPHIC REGION
12.1 Global SHR0302 Market Size Forecast by Region
12.1.1 Global SHR0302 Forecast by Region (2027-2032)
12.1.2 Global SHR0302 Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global SHR0302 Forecast by Type (2027-2032)
12.7 Global SHR0302 Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Jiangsu Hengrui Pharmaceuticals
13.1.1 Jiangsu Hengrui Pharmaceuticals Company Information
13.1.2 Jiangsu Hengrui Pharmaceuticals SHR0302 Product Portfolios and Specifications
13.1.3 Jiangsu Hengrui Pharmaceuticals SHR0302 Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
13.1.5 Jiangsu Hengrui Pharmaceuticals Latest Developments
13.2 Arcutis Biotherapeutics
13.2.1 Arcutis Biotherapeutics Company Information
13.2.2 Arcutis Biotherapeutics SHR0302 Product Portfolios and Specifications
13.2.3 Arcutis Biotherapeutics SHR0302 Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Arcutis Biotherapeutics Main Business Overview
13.2.5 Arcutis Biotherapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. SHR0302 Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. SHR0302 Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 4mg / tablet
Table 4. Major Players of 8mg / tablet
Table 5. Global SHR0302 Sales by Type (2021-2026) & (Units)
Table 6. Global SHR0302 Sales Market Share by Type (2021-2026)
Table 7. Global SHR0302 Revenue by Type (2021-2026) & ($ million)
Table 8. Global SHR0302 Revenue Market Share by Type (2021-2026)
Table 9. Global SHR0302 Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of OralTablet
Table 11. Major Players of Topical Ointment
Table 12. Major Players of Gel Dosage Form
Table 13. Global SHR0302 Sales by Dosage Form (2021-2026) & (Units)
Table 14. Global SHR0302 Sales Market Share by Dosage Form (2021-2026)
Table 15. Global SHR0302 Revenue by Dosage Form (2021-2026) & ($ million)
Table 16. Global SHR0302 Revenue Market Share by Dosage Form (2021-2026)
Table 17. Global SHR0302 Sale Price by Dosage Form (2021-2026) & (US$/Unit)
Table 18. Major Players of Oral Administration
Table 19. Major Players of Topical Administration
Table 20. Global SHR0302 Sales by Route of Administration (2021-2026) & (Units)
Table 21. Global SHR0302 Sales Market Share by Route of Administration (2021-2026)
Table 22. Global SHR0302 Revenue by Route of Administration (2021-2026) & ($ million)
Table 23. Global SHR0302 Revenue Market Share by Route of Administration (2021-2026)
Table 24. Global SHR0302 Sale Price by Route of Administration (2021-2026) & (US$/Unit)
Table 25. Major Players of Hospital
Table 26. Major Players of Retail
Table 27. Major Players of Online
Table 28. Global SHR0302 Sales by Sales Channels (2021-2026) & (Units)
Table 29. Global SHR0302 Sales Market Share by Sales Channels (2021-2026)
Table 30. Global SHR0302 Revenue by Sales Channels (2021-2026) & ($ million)
Table 31. Global SHR0302 Revenue Market Share by Sales Channels (2021-2026)
Table 32. Global SHR0302 Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 33. Global SHR0302 Sale by Application (2021-2026) & (Units)
Table 34. Global SHR0302 Sale Market Share by Application (2021-2026)
Table 35. Global SHR0302 Revenue by Application (2021-2026) & ($ million)
Table 36. Global SHR0302 Revenue Market Share by Application (2021-2026)
Table 37. Global SHR0302 Sale Price by Application (2021-2026) & (US$/Unit)
Table 38. Global SHR0302 Sales by Company (2021-2026) & (Units)
Table 39. Global SHR0302 Sales Market Share by Company (2021-2026)
Table 40. Global SHR0302 Revenue by Company (2021-2026) & ($ millions)
Table 41. Global SHR0302 Revenue Market Share by Company (2021-2026)
Table 42. Global SHR0302 Sale Price by Company (2021-2026) & (US$/Unit)
Table 43. Key Manufacturers SHR0302 Producing Area Distribution and Sales Area
Table 44. Players SHR0302 Products Offered
Table 45. SHR0302 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 46. New Products and Potential Entrants
Table 47. Market M&A Activity & Strategy
Table 48. Global SHR0302 Sales by Geographic Region (2021-2026) & (Units)
Table 49. Global SHR0302 Sales Market Share Geographic Region (2021-2026)
Table 50. Global SHR0302 Revenue by Geographic Region (2021-2026) & ($ millions)
Table 51. Global SHR0302 Revenue Market Share by Geographic Region (2021-2026)
Table 52. Global SHR0302 Sales by Country/Region (2021-2026) & (Units)
Table 53. Global SHR0302 Sales Market Share by Country/Region (2021-2026)
Table 54. Global SHR0302 Revenue by Country/Region (2021-2026) & ($ millions)
Table 55. Global SHR0302 Revenue Market Share by Country/Region (2021-2026)
Table 56. Americas SHR0302 Sales by Country (2021-2026) & (Units)
Table 57. Americas SHR0302 Sales Market Share by Country (2021-2026)
Table 58. Americas SHR0302 Revenue by Country (2021-2026) & ($ millions)
Table 59. Americas SHR0302 Sales by Type (2021-2026) & (Units)
Table 60. Americas SHR0302 Sales by Application (2021-2026) & (Units)
Table 61. APAC SHR0302 Sales by Region (2021-2026) & (Units)
Table 62. APAC SHR0302 Sales Market Share by Region (2021-2026)
Table 63. APAC SHR0302 Revenue by Region (2021-2026) & ($ millions)
Table 64. APAC SHR0302 Sales by Type (2021-2026) & (Units)
Table 65. APAC SHR0302 Sales by Application (2021-2026) & (Units)
Table 66. Europe SHR0302 Sales by Country (2021-2026) & (Units)
Table 67. Europe SHR0302 Revenue by Country (2021-2026) & ($ millions)
Table 68. Europe SHR0302 Sales by Type (2021-2026) & (Units)
Table 69. Europe SHR0302 Sales by Application (2021-2026) & (Units)
Table 70. Middle East & Africa SHR0302 Sales by Country (2021-2026) & (Units)
Table 71. Middle East & Africa SHR0302 Revenue Market Share by Country (2021-2026)
Table 72. Middle East & Africa SHR0302 Sales by Type (2021-2026) & (Units)
Table 73. Middle East & Africa SHR0302 Sales by Application (2021-2026) & (Units)
Table 74. Key Market Drivers & Growth Opportunities of SHR0302
Table 75. Key Market Challenges & Risks of SHR0302
Table 76. Key Industry Trends of SHR0302
Table 77. SHR0302 Raw Material
Table 78. Key Suppliers of Raw Materials
Table 79. SHR0302 Distributors List
Table 80. SHR0302 Customer List
Table 81. Global SHR0302 Sales Forecast by Region (2027-2032) & (Units)
Table 82. Global SHR0302 Revenue Forecast by Region (2027-2032) & ($ millions)
Table 83. Americas SHR0302 Sales Forecast by Country (2027-2032) & (Units)
Table 84. Americas SHR0302 Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. APAC SHR0302 Sales Forecast by Region (2027-2032) & (Units)
Table 86. APAC SHR0302 Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 87. Europe SHR0302 Sales Forecast by Country (2027-2032) & (Units)
Table 88. Europe SHR0302 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 89. Middle East & Africa SHR0302 Sales Forecast by Country (2027-2032) & (Units)
Table 90. Middle East & Africa SHR0302 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 91. Global SHR0302 Sales Forecast by Type (2027-2032) & (Units)
Table 92. Global SHR0302 Revenue Forecast by Type (2027-2032) & ($ millions)
Table 93. Global SHR0302 Sales Forecast by Application (2027-2032) & (Units)
Table 94. Global SHR0302 Revenue Forecast by Application (2027-2032) & ($ millions)
Table 95. Jiangsu Hengrui Pharmaceuticals Basic Information, SHR0302 Manufacturing Base, Sales Area and Its Competitors
Table 96. Jiangsu Hengrui Pharmaceuticals SHR0302 Product Portfolios and Specifications
Table 97. Jiangsu Hengrui Pharmaceuticals SHR0302 Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Jiangsu Hengrui Pharmaceuticals Main Business
Table 99. Jiangsu Hengrui Pharmaceuticals Latest Developments
Table 100. Arcutis Biotherapeutics Basic Information, SHR0302 Manufacturing Base, Sales Area and Its Competitors
Table 101. Arcutis Biotherapeutics SHR0302 Product Portfolios and Specifications
Table 102. Arcutis Biotherapeutics SHR0302 Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Arcutis Biotherapeutics Main Business
Table 104. Arcutis Biotherapeutics Latest Developments
Table 1. SHR0302 Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. SHR0302 Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 4mg / tablet
Table 4. Major Players of 8mg / tablet
Table 5. Global SHR0302 Sales by Type (2021-2026) & (Units)
Table 6. Global SHR0302 Sales Market Share by Type (2021-2026)
Table 7. Global SHR0302 Revenue by Type (2021-2026) & ($ million)
Table 8. Global SHR0302 Revenue Market Share by Type (2021-2026)
Table 9. Global SHR0302 Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of OralTablet
Table 11. Major Players of Topical Ointment
Table 12. Major Players of Gel Dosage Form
Table 13. Global SHR0302 Sales by Dosage Form (2021-2026) & (Units)
Table 14. Global SHR0302 Sales Market Share by Dosage Form (2021-2026)
Table 15. Global SHR0302 Revenue by Dosage Form (2021-2026) & ($ million)
Table 16. Global SHR0302 Revenue Market Share by Dosage Form (2021-2026)
Table 17. Global SHR0302 Sale Price by Dosage Form (2021-2026) & (US$/Unit)
Table 18. Major Players of Oral Administration
Table 19. Major Players of Topical Administration
Table 20. Global SHR0302 Sales by Route of Administration (2021-2026) & (Units)
Table 21. Global SHR0302 Sales Market Share by Route of Administration (2021-2026)
Table 22. Global SHR0302 Revenue by Route of Administration (2021-2026) & ($ million)
Table 23. Global SHR0302 Revenue Market Share by Route of Administration (2021-2026)
Table 24. Global SHR0302 Sale Price by Route of Administration (2021-2026) & (US$/Unit)
Table 25. Major Players of Hospital
Table 26. Major Players of Retail
Table 27. Major Players of Online
Table 28. Global SHR0302 Sales by Sales Channels (2021-2026) & (Units)
Table 29. Global SHR0302 Sales Market Share by Sales Channels (2021-2026)
Table 30. Global SHR0302 Revenue by Sales Channels (2021-2026) & ($ million)
Table 31. Global SHR0302 Revenue Market Share by Sales Channels (2021-2026)
Table 32. Global SHR0302 Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 33. Global SHR0302 Sale by Application (2021-2026) & (Units)
Table 34. Global SHR0302 Sale Market Share by Application (2021-2026)
Table 35. Global SHR0302 Revenue by Application (2021-2026) & ($ million)
Table 36. Global SHR0302 Revenue Market Share by Application (2021-2026)
Table 37. Global SHR0302 Sale Price by Application (2021-2026) & (US$/Unit)
Table 38. Global SHR0302 Sales by Company (2021-2026) & (Units)
Table 39. Global SHR0302 Sales Market Share by Company (2021-2026)
Table 40. Global SHR0302 Revenue by Company (2021-2026) & ($ millions)
Table 41. Global SHR0302 Revenue Market Share by Company (2021-2026)
Table 42. Global SHR0302 Sale Price by Company (2021-2026) & (US$/Unit)
Table 43. Key Manufacturers SHR0302 Producing Area Distribution and Sales Area
Table 44. Players SHR0302 Products Offered
Table 45. SHR0302 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 46. New Products and Potential Entrants
Table 47. Market M&A Activity & Strategy
Table 48. Global SHR0302 Sales by Geographic Region (2021-2026) & (Units)
Table 49. Global SHR0302 Sales Market Share Geographic Region (2021-2026)
Table 50. Global SHR0302 Revenue by Geographic Region (2021-2026) & ($ millions)
Table 51. Global SHR0302 Revenue Market Share by Geographic Region (2021-2026)
Table 52. Global SHR0302 Sales by Country/Region (2021-2026) & (Units)
Table 53. Global SHR0302 Sales Market Share by Country/Region (2021-2026)
Table 54. Global SHR0302 Revenue by Country/Region (2021-2026) & ($ millions)
Table 55. Global SHR0302 Revenue Market Share by Country/Region (2021-2026)
Table 56. Americas SHR0302 Sales by Country (2021-2026) & (Units)
Table 57. Americas SHR0302 Sales Market Share by Country (2021-2026)
Table 58. Americas SHR0302 Revenue by Country (2021-2026) & ($ millions)
Table 59. Americas SHR0302 Sales by Type (2021-2026) & (Units)
Table 60. Americas SHR0302 Sales by Application (2021-2026) & (Units)
Table 61. APAC SHR0302 Sales by Region (2021-2026) & (Units)
Table 62. APAC SHR0302 Sales Market Share by Region (2021-2026)
Table 63. APAC SHR0302 Revenue by Region (2021-2026) & ($ millions)
Table 64. APAC SHR0302 Sales by Type (2021-2026) & (Units)
Table 65. APAC SHR0302 Sales by Application (2021-2026) & (Units)
Table 66. Europe SHR0302 Sales by Country (2021-2026) & (Units)
Table 67. Europe SHR0302 Revenue by Country (2021-2026) & ($ millions)
Table 68. Europe SHR0302 Sales by Type (2021-2026) & (Units)
Table 69. Europe SHR0302 Sales by Application (2021-2026) & (Units)
Table 70. Middle East & Africa SHR0302 Sales by Country (2021-2026) & (Units)
Table 71. Middle East & Africa SHR0302 Revenue Market Share by Country (2021-2026)
Table 72. Middle East & Africa SHR0302 Sales by Type (2021-2026) & (Units)
Table 73. Middle East & Africa SHR0302 Sales by Application (2021-2026) & (Units)
Table 74. Key Market Drivers & Growth Opportunities of SHR0302
Table 75. Key Market Challenges & Risks of SHR0302
Table 76. Key Industry Trends of SHR0302
Table 77. SHR0302 Raw Material
Table 78. Key Suppliers of Raw Materials
Table 79. SHR0302 Distributors List
Table 80. SHR0302 Customer List
Table 81. Global SHR0302 Sales Forecast by Region (2027-2032) & (Units)
Table 82. Global SHR0302 Revenue Forecast by Region (2027-2032) & ($ millions)
Table 83. Americas SHR0302 Sales Forecast by Country (2027-2032) & (Units)
Table 84. Americas SHR0302 Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. APAC SHR0302 Sales Forecast by Region (2027-2032) & (Units)
Table 86. APAC SHR0302 Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 87. Europe SHR0302 Sales Forecast by Country (2027-2032) & (Units)
Table 88. Europe SHR0302 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 89. Middle East & Africa SHR0302 Sales Forecast by Country (2027-2032) & (Units)
Table 90. Middle East & Africa SHR0302 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 91. Global SHR0302 Sales Forecast by Type (2027-2032) & (Units)
Table 92. Global SHR0302 Revenue Forecast by Type (2027-2032) & ($ millions)
Table 93. Global SHR0302 Sales Forecast by Application (2027-2032) & (Units)
Table 94. Global SHR0302 Revenue Forecast by Application (2027-2032) & ($ millions)
Table 95. Jiangsu Hengrui Pharmaceuticals Basic Information, SHR0302 Manufacturing Base, Sales Area and Its Competitors
Table 96. Jiangsu Hengrui Pharmaceuticals SHR0302 Product Portfolios and Specifications
Table 97. Jiangsu Hengrui Pharmaceuticals SHR0302 Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Jiangsu Hengrui Pharmaceuticals Main Business
Table 99. Jiangsu Hengrui Pharmaceuticals Latest Developments
Table 100. Arcutis Biotherapeutics Basic Information, SHR0302 Manufacturing Base, Sales Area and Its Competitors
Table 101. Arcutis Biotherapeutics SHR0302 Product Portfolios and Specifications
Table 102. Arcutis Biotherapeutics SHR0302 Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Arcutis Biotherapeutics Main Business
Table 104. Arcutis Biotherapeutics Latest Developments
LIST OF FIGURES
Figure 1. Picture of SHR0302
Figure 2. SHR0302 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global SHR0302 Sales Growth Rate 2021-2032 (Units)
Figure 7. Global SHR0302 Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. SHR0302 Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. SHR0302 Sales Market Share by Country/Region (2025)
Figure 10. SHR0302 Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 4mg / tablet
Figure 12. Product Picture of 8mg / tablet
Figure 13. Global SHR0302 Sales Market Share by Type in 2026
Figure 14. Global SHR0302 Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of OralTablet
Figure 16. Product Picture of Topical Ointment
Figure 17. Product Picture of Gel Dosage Form
Figure 18. Global SHR0302 Sales Market Share by Dosage Form in 2026
Figure 19. Global SHR0302 Revenue Market Share by Dosage Form (2021-2026)
Figure 20. Product Picture of Oral Administration
Figure 21. Product Picture of Topical Administration
Figure 22. Global SHR0302 Sales Market Share by Route of Administration in 2026
Figure 23. Global SHR0302 Revenue Market Share by Route of Administration (2021-2026)
Figure 24. Product Picture of Hospital
Figure 25. Product Picture of Retail
Figure 26. Product Picture of Online
Figure 27. Global SHR0302 Sales Market Share by Sales Channels in 2026
Figure 28. Global SHR0302 Revenue Market Share by Sales Channels (2021-2026)
Figure 29. SHR0302 Consumed in Inflammatory Skin Diseases Such As Atopic Dermatitis, Psoriasis, Vitiligo And Alopecia Areata
Figure 30. Global SHR0302 Market: Inflammatory Skin Diseases Such As Atopic Dermatitis, Psoriasis, Vitiligo And Alopecia Areata (2021-2026) & (Units)
Figure 31. SHR0302 Consumed in Rheumatic Immune Diseases Such As Rheumatoid Arthritis And Ankylosing Spondylitis
Figure 32. Global SHR0302 Market: Rheumatic Immune Diseases Such As Rheumatoid Arthritis And Ankylosing Spondylitis (2021-2026) & (Units)
Figure 33. SHR0302 Consumed in Other Autoimmune And Inflammatory Diseases Mediated By The JAK Pathway
Figure 34. Global SHR0302 Market: Other Autoimmune And Inflammatory Diseases Mediated By The JAK Pathway (2021-2026) & (Units)
Figure 35. SHR0302 Consumed in Others
Figure 36. Global SHR0302 Market: Others (2021-2026) & (Units)
Figure 37. Global SHR0302 Sale Market Share by Application (2025)
Figure 38. Global SHR0302 Revenue Market Share by Application in 2025
Figure 39. SHR0302 Sales by Company in 2025 (Units)
Figure 40. Global SHR0302 Sales Market Share by Company in 2025
Figure 41. SHR0302 Revenue by Company in 2025 ($ millions)
Figure 42. Global SHR0302 Revenue Market Share by Company in 2025
Figure 43. Global SHR0302 Sales Market Share by Geographic Region (2021-2026)
Figure 44. Global SHR0302 Revenue Market Share by Geographic Region in 2025
Figure 45. Americas SHR0302 Sales 2021-2026 (Units)
Figure 46. Americas SHR0302 Revenue 2021-2026 ($ millions)
Figure 47. APAC SHR0302 Sales 2021-2026 (Units)
Figure 48. APAC SHR0302 Revenue 2021-2026 ($ millions)
Figure 49. Europe SHR0302 Sales 2021-2026 (Units)
Figure 50. Europe SHR0302 Revenue 2021-2026 ($ millions)
Figure 51. Middle East & Africa SHR0302 Sales 2021-2026 (Units)
Figure 52. Middle East & Africa SHR0302 Revenue 2021-2026 ($ millions)
Figure 53. Americas SHR0302 Sales Market Share by Country in 2025
Figure 54. Americas SHR0302 Revenue Market Share by Country (2021-2026)
Figure 55. Americas SHR0302 Sales Market Share by Type (2021-2026)
Figure 56. Americas SHR0302 Sales Market Share by Application (2021-2026)
Figure 57. United States SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 58. Canada SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 59. Mexico SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 60. Brazil SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 61. APAC SHR0302 Sales Market Share by Region in 2025
Figure 62. APAC SHR0302 Revenue Market Share by Region (2021-2026)
Figure 63. APAC SHR0302 Sales Market Share by Type (2021-2026)
Figure 64. APAC SHR0302 Sales Market Share by Application (2021-2026)
Figure 65. China SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 66. Japan SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 67. South Korea SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 68. Southeast Asia SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 69. India SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 70. Australia SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 71. China Taiwan SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 72. Europe SHR0302 Sales Market Share by Country in 2025
Figure 73. Europe SHR0302 Revenue Market Share by Country (2021-2026)
Figure 74. Europe SHR0302 Sales Market Share by Type (2021-2026)
Figure 75. Europe SHR0302 Sales Market Share by Application (2021-2026)
Figure 76. Germany SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 77. France SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 78. UK SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 79. Italy SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 80. Russia SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 81. Middle East & Africa SHR0302 Sales Market Share by Country (2021-2026)
Figure 82. Middle East & Africa SHR0302 Sales Market Share by Type (2021-2026)
Figure 83. Middle East & Africa SHR0302 Sales Market Share by Application (2021-2026)
Figure 84. Egypt SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 85. South Africa SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 86. Israel SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 87. Turkey SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 88. GCC Countries SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 89. Manufacturing Cost Structure Analysis of SHR0302 in 2026
Figure 90. Manufacturing Process Analysis of SHR0302
Figure 91. Industry Chain Structure of SHR0302
Figure 92. Channels of Distribution
Figure 93. Global SHR0302 Sales Market Forecast by Region (2027-2032)
Figure 94. Global SHR0302 Revenue Market Share Forecast by Region (2027-2032)
Figure 95. Global SHR0302 Sales Market Share Forecast by Type (2027-2032)
Figure 96. Global SHR0302 Revenue Market Share Forecast by Type (2027-2032)
Figure 97. Global SHR0302 Sales Market Share Forecast by Application (2027-2032)
Figure 98. Global SHR0302 Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of SHR0302
Figure 2. SHR0302 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global SHR0302 Sales Growth Rate 2021-2032 (Units)
Figure 7. Global SHR0302 Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. SHR0302 Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. SHR0302 Sales Market Share by Country/Region (2025)
Figure 10. SHR0302 Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 4mg / tablet
Figure 12. Product Picture of 8mg / tablet
Figure 13. Global SHR0302 Sales Market Share by Type in 2026
Figure 14. Global SHR0302 Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of OralTablet
Figure 16. Product Picture of Topical Ointment
Figure 17. Product Picture of Gel Dosage Form
Figure 18. Global SHR0302 Sales Market Share by Dosage Form in 2026
Figure 19. Global SHR0302 Revenue Market Share by Dosage Form (2021-2026)
Figure 20. Product Picture of Oral Administration
Figure 21. Product Picture of Topical Administration
Figure 22. Global SHR0302 Sales Market Share by Route of Administration in 2026
Figure 23. Global SHR0302 Revenue Market Share by Route of Administration (2021-2026)
Figure 24. Product Picture of Hospital
Figure 25. Product Picture of Retail
Figure 26. Product Picture of Online
Figure 27. Global SHR0302 Sales Market Share by Sales Channels in 2026
Figure 28. Global SHR0302 Revenue Market Share by Sales Channels (2021-2026)
Figure 29. SHR0302 Consumed in Inflammatory Skin Diseases Such As Atopic Dermatitis, Psoriasis, Vitiligo And Alopecia Areata
Figure 30. Global SHR0302 Market: Inflammatory Skin Diseases Such As Atopic Dermatitis, Psoriasis, Vitiligo And Alopecia Areata (2021-2026) & (Units)
Figure 31. SHR0302 Consumed in Rheumatic Immune Diseases Such As Rheumatoid Arthritis And Ankylosing Spondylitis
Figure 32. Global SHR0302 Market: Rheumatic Immune Diseases Such As Rheumatoid Arthritis And Ankylosing Spondylitis (2021-2026) & (Units)
Figure 33. SHR0302 Consumed in Other Autoimmune And Inflammatory Diseases Mediated By The JAK Pathway
Figure 34. Global SHR0302 Market: Other Autoimmune And Inflammatory Diseases Mediated By The JAK Pathway (2021-2026) & (Units)
Figure 35. SHR0302 Consumed in Others
Figure 36. Global SHR0302 Market: Others (2021-2026) & (Units)
Figure 37. Global SHR0302 Sale Market Share by Application (2025)
Figure 38. Global SHR0302 Revenue Market Share by Application in 2025
Figure 39. SHR0302 Sales by Company in 2025 (Units)
Figure 40. Global SHR0302 Sales Market Share by Company in 2025
Figure 41. SHR0302 Revenue by Company in 2025 ($ millions)
Figure 42. Global SHR0302 Revenue Market Share by Company in 2025
Figure 43. Global SHR0302 Sales Market Share by Geographic Region (2021-2026)
Figure 44. Global SHR0302 Revenue Market Share by Geographic Region in 2025
Figure 45. Americas SHR0302 Sales 2021-2026 (Units)
Figure 46. Americas SHR0302 Revenue 2021-2026 ($ millions)
Figure 47. APAC SHR0302 Sales 2021-2026 (Units)
Figure 48. APAC SHR0302 Revenue 2021-2026 ($ millions)
Figure 49. Europe SHR0302 Sales 2021-2026 (Units)
Figure 50. Europe SHR0302 Revenue 2021-2026 ($ millions)
Figure 51. Middle East & Africa SHR0302 Sales 2021-2026 (Units)
Figure 52. Middle East & Africa SHR0302 Revenue 2021-2026 ($ millions)
Figure 53. Americas SHR0302 Sales Market Share by Country in 2025
Figure 54. Americas SHR0302 Revenue Market Share by Country (2021-2026)
Figure 55. Americas SHR0302 Sales Market Share by Type (2021-2026)
Figure 56. Americas SHR0302 Sales Market Share by Application (2021-2026)
Figure 57. United States SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 58. Canada SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 59. Mexico SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 60. Brazil SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 61. APAC SHR0302 Sales Market Share by Region in 2025
Figure 62. APAC SHR0302 Revenue Market Share by Region (2021-2026)
Figure 63. APAC SHR0302 Sales Market Share by Type (2021-2026)
Figure 64. APAC SHR0302 Sales Market Share by Application (2021-2026)
Figure 65. China SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 66. Japan SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 67. South Korea SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 68. Southeast Asia SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 69. India SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 70. Australia SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 71. China Taiwan SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 72. Europe SHR0302 Sales Market Share by Country in 2025
Figure 73. Europe SHR0302 Revenue Market Share by Country (2021-2026)
Figure 74. Europe SHR0302 Sales Market Share by Type (2021-2026)
Figure 75. Europe SHR0302 Sales Market Share by Application (2021-2026)
Figure 76. Germany SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 77. France SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 78. UK SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 79. Italy SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 80. Russia SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 81. Middle East & Africa SHR0302 Sales Market Share by Country (2021-2026)
Figure 82. Middle East & Africa SHR0302 Sales Market Share by Type (2021-2026)
Figure 83. Middle East & Africa SHR0302 Sales Market Share by Application (2021-2026)
Figure 84. Egypt SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 85. South Africa SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 86. Israel SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 87. Turkey SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 88. GCC Countries SHR0302 Revenue Growth 2021-2026 ($ millions)
Figure 89. Manufacturing Cost Structure Analysis of SHR0302 in 2026
Figure 90. Manufacturing Process Analysis of SHR0302
Figure 91. Industry Chain Structure of SHR0302
Figure 92. Channels of Distribution
Figure 93. Global SHR0302 Sales Market Forecast by Region (2027-2032)
Figure 94. Global SHR0302 Revenue Market Share Forecast by Region (2027-2032)
Figure 95. Global SHR0302 Sales Market Share Forecast by Type (2027-2032)
Figure 96. Global SHR0302 Revenue Market Share Forecast by Type (2027-2032)
Figure 97. Global SHR0302 Sales Market Share Forecast by Application (2027-2032)
Figure 98. Global SHR0302 Revenue Market Share Forecast by Application (2027-2032)
